Dr. Reddy's Laboratories Limited Dr. Reddy’s (NYSE: RDY) Unveil Ertapenem for Injection in the U.S. Market Dr. Reddy’s Laboratories Limited (NYSE: RDY) disclosed Wednesday that it has unveiled Ertapenem for Injection, 1 g/vial, a therapeutic equivalent generic version of INVANZ (ertapenem for injection) for
Dr. Reddy's Laboratories Limited Dr. Reddy’s (NYSE: RDY) Introduces Fluphenazine Hydrochloride Tablets Dr. Reddy’s Laboratories Limited (NYSE: RDY) has introduced the Fluphenazine Hydrochloride Tablets, USP is US markets. The tablets are authorized by FDA.
